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Constitutive expression of the neuron-restrictive
silencer factor (NRSF)yREST in differentiating
neurons disrupts neuronal gene expression
and causes axon pathfinding errors in vivo
Alice J. Paquette*†, Sharon E. Perez*‡, and David J. Anderson*§¶
§Howard Hughes Medical Institute, Division of Biology 216–76, *California Institute of Technology, Pasadena, CA 91125
Communicated by Masakazu Konishi, California Institute of Technology, Pasadena, CA, August 4, 2000 (received for review June 20, 2000)
The neuron-restrictive silencer factor (NRSF; also known as REST for
repressor element-1 silencing transcription factor) is a transcrip-
tional repressor of multiple neuronal genes, but little is known
about its function in vivo. NRSF is normally down-regulated upon
neuronal differentiation. Constitutive expression of NRSF in the
developing spinal cord of chicken embryos caused repression of
two endogenous target genes, N-tubulin and Ng-CAM, but did not
prevent overt neurogenesis. Nevertheless, commissural neurons
that differentiated while constitutively expressing NRSF showed a
significantly increased frequency of axon guidance errors. These
data suggest that down-regulation of NRSF is necessary for the
proper development of at least some classes of neurons in vivo.
The determination and differentiation of neurons is governedby a complex transcriptional program involving both posi-
tive- and negative-acting factors. Although a great deal has been
learned recently about positive transcriptional determinants of
the neuronal fate, much less is known about negative regulators
(1–3). In fact, the only transcription factor currently known to
inhibit neurogenesis in vivo is Hes1, a basic helix–loop–helix
factor that is a downstream target of Notch signaling (4–6). Hes1
acts early in the transcriptional cascade to inhibit basic helix–
loop–helix neuronal determination genes, however, rather than
as a direct negative regulator of genes characteristic of terminal
neuronal differentiation.
The neuron-restrictive silencer factor (NRSF; also known as
REST for repressor element-1 silencing transcription factor) is
a zinc-finger transcription factor isolated based on its ability to
repress transcription from the promoters of neuron-specific,
terminal differentiation (‘‘structural’’) genes in nonneuronal
cells (7, 8). Upwards of 30 different neuronal genes have been
shown to contain a consensus 21-bp NRSF-binding site (the
NRSE) (9). Such genes encode a broad range of molecules
involved in neuronal development and function, including ion
channels (10), neurotransmitter receptors (11–16) and their
synthesizing enzymes (17), neurotrophins (18), synaptic vesicle
proteins (19, 20), adhesion molecules (21, 22), growth-associated
(23), and cytoskeletal proteins (9, 24).
Expression studies have indicated that NRSF mRNA is
present at much higher levels in nonneuronal than in neuronal
cells and tissues. Furthermore, in the developing nervous system,
NRSF is expressed at higher levels in the ventricular zone than
in the marginal zone (7, 8, 24). These data have suggested that
NRSF might function in part to repress neuronal gene expression
in both nonneuronal tissues and neural precursors. They also
imply that down-regulation of NRSF during neurogenesis may be
important for proper neuronal differentiation. At apparent odds
with this latter idea is the observation that NRSF is expressed at
low levels by most neurons in the adult brain (25). Whether this
low level has any functional significance, however, is not yet
clear; indeed, neurons (but not nonneuronal cells) have recently
been shown to express a splice variant of NRSF (25) that acts as
a dominant inhibitor of NRSF function in neuronal cell
lines (26).
Despite the panoply of potential NRSF targets, its suggestive
pattern of expression and a wealth of in vitro and biochemical
data, it has been difficult to establish the precise functional role
of NRSF in vivo. NRSFyRest mutant mouse embryos begin to
degenerate at embryonic day 9.0–9.5 of gestation (24), indicating
an essential function in early development but precluding a clear
analysis of its role in central nervous system neuronal differen-
tiation, which mostly occurs after this stage. However, mosaic
expression of a dominant-negative form of NRSF in the devel-
oping chick spinal cord resulted in precocious expression of some
neuronal target genes in neural progenitors (24). Although frank
neuronal differentiation within the ventricular zone was not
observed, these experiments provided in vivo evidence that
expression of NRSF in neural progenitors is functionally impor-
tant to prevent premature initiation of neuronal gene expression
during development.
An important question not addressed by these previous studies
is whether down-regulation of NRSF expression during neuro-
genesis is required for proper neuronal differentiation. To
address this question we have constitutively expressed NRSF in
differentiating neuroblasts and their progeny in vivo. This per-
turbation leads to a down-regulation of certain endogenous
NRSF target genes, which are, conversely, up-regulated by
loss-of-function manipulations (24). To assess the consequence
of this gain-of-function manipulation more generally for the
proper development of neuronal morphology and connectivity,
we have used a tauGFP marker to trace the axonal projections
of the cells in which sustained expression of NRSF was achieved.
Although in general NRSF-overexpressing cells develop an
apparently normal neuronal morphology, significantly more
commissural neurons exhibit axon pathfinding errors than in
controls. These results provide evidence that down-regulation of
NRSF during neurogenesis is necessary for proper development
of an important aspect of the neuronal phenotype by at least
some classes of neurons, in vivo.
Materials and Methods
Plasmid Construction. Expression constructs harboring a full-
length (3.25-kb) murine NRSF cDNA (C. J. Schoenherr and
D.J.A., unpublished work) were made in the nonintegrating
plasmid vector pCS21 (27, 28) and the replication-competent
Abbreviations: NRSF, neuron-restrictive silencer factor; NTG, NRSF-IRES-tauGFP; TG,
tauGFP.
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retroviral vector RCASBP(B) (29). These constructs were de-
signed to include as little of the 59 and 39 untranslated regions
as possible: 140 bp of 59 untranslated region and 40 bp of 39
untranslated region. Nuclear-localized b-galactosidase was ex-
pressed from the construct pCS2 1 n-bgal (27, 28). TauGFP was
a derivative of mGFP6 (30). Details of the vector construction
procedures are available on request.
Electroporation. White Leghorn chicken eggs were incubated at
38°C until stages 12–15 of development (31), or about 16–25
somites, embryonic day 2. Supercoiled plasmid for electropora-
tion was used at a concentration of 1 or 2 mgyml in TE (10 mM
Trisy1 mM EDTA, pH 7.5) with 0.025% Fast Green (Sigma).
Embryos were injected with DNA solution into the lumen of the
neural tube and then subjected to electroporation using a BTX
ElectroSquarePorator, BTX Genetrodes, and accompanying
equipment (Genetronics). The electrodes were spaced 6–8 mm
apart and positioned such that the DNA was driven into the cells
on only one side of the neural tube. Embryos were pulsed five
times for 50 ms each at 25 V. Eggs were then reincubated for 2
or 3 days before the embryos were fixed for 2 h at 4°C in 4%
paraformaldehyde in PBS. Embryos were then washed in PBS,
cryoprotected with 30% sucrose, mounted in OCT (Tissue-Tek),
and sectioned at 20 mm at lower cervical and thoracic levels.
Immunohistochemistry. Antibody staining of sectioned tissue was
carried out by incubating sections overnight at 4°C with the
following primary antibodies at the indicated dilutions. Mouse
monoclonal antibodies to: murine NRSF (12C11; ref. 24), un-
diluted; neuron-specific tubulin (TuJ1, BAbCo), 1:1000; Ng-
CAM (8D9, Developmental Studies Hybridoma Bank), 1:10;
cyn-1 (32), 1:5; and neurofilament (NN18, Sigma) 1:250. Rabbit
polyclonal antibodies to: b-galactosidase (59–39), 1:500; GFP
(CLONTECH), 1:1000; SCG10 (33), 1:1000. Samples were
developed using Alexa dye-conjugated secondary antibodies
(488 and 568, Molecular Probes) and visualized using a Zeiss
Axioskop fluorescence microscope.
Quantitative Analysis of Axon Guidance Errors. The number of stray
tauGFP1 axons in the ventrolateral quadrant of the spinal cord
contralateral to the electroporated side was counted in a blinded
manner on coded photographs of sections from each of 11
NRSF-IRES-tauGFP (NTG)-expressing and 7 tauGFP (TG)-
expressing embryos collected from two separate electroporation
sessions. A total of 38 randomly selected sections from NTG
embryos and 40 sections from TG embryos were scored. The
average number of stray axons per section was calculated for
each embryo, and the mean of these average values was com-
pared between NTG- and TG-expressing embryos. Statistical
significance was computed using a two-tailed Student’s t test.
Results
Repression of Endogenous Target Genes by Overexpression of NRSF.
An important step in neurogenesis is the induction of neuronal,
terminal differentiation (or ‘‘structural’’) gene expression. In the
developing spinal cord, neural progenitors in the ventricular
zone normally express low levels of class III b-tubulin (or
N-tubulin) (Fig. 1B, arrowhead), and newly born neurons in the
marginal zone quickly up-regulate it to high levels (Fig. 1B, open
arrow). Expression of the neuron-glial cell adhesion molecule
(Ng-CAM) is also up-regulated during neuronal differentiation,
but unlike N-tubulin, it is not detectable until the cells have
migrated to the marginal zone (Fig. 1D, open arrow). Impor-
tantly, N-tubulin and NgCAM are both NRSF direct target genes
(9) that have been previously shown to be prematurely up-
regulated by inhibition of NRSF function in vivo (24).
To assess the effect of sustained NRSF expression on the
induction of neuronal gene expression in vivo, we electroporated
chick embryos with a full-length mouse NRSF cDNA expressed
from a replication-competent retroviral vector, RCASBP(B)
(29). Although the 3.43-kb NRSF insert exceeds the theoretical
Fig. 1. Overexpression of NRSF results in repression of direct neuronal target
genes. A and B, C and D, E and F, and G and H illustrate pairs of adjacent
sections stained with antibodies to mouse NRSF (A, C, E, and G), N-tubulin (B
and F), and Ng-CAM (D and H). A–D represent sections from one embryo and
E–H represent sections from another embryo. Exogenous NRSF is expressed
throughout the ventricular (A, arrowhead) and marginal (A, arrow) zones on
the electroporated (right) side of both embryos (see also C, E, and G). N-tubulin
expression is repressed by NRSF in the ventricular zone (B and F, arrows; cf. B,
arrowhead) but not in the marginal zone (F, open arrowhead) on the elec-
troporated (right) but not the contralateral (left) side of the spinal cord (cf. A
vs. B, E vs. F). Ng-CAM expression is reduced in axons of commissural neurons
in the marginal zone (D and H, arrowheads; cf. D, open arrow), sensory axons
in the DREZ (D, right vs. left arrows), and neurons of the DRG (D, open
arrowhead). Levels of Ng-CAM expression also appear lower in the ventral
funiculus of the spinal cord on the electroporated side relative to controls (D
and H, white arrowheads), because much of this staining represents the axons
of ipsilateral commissural neurons located more dorsally, in which NRSF
expression is high (C and G). In addition, NRSF may also repress Ng-CAM
expression in neurons differentiating within the ventrolateral quadrant (see
also Fig. 2 B and D).
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packaging limit of 2.4 kb (29) for the generation of infectious
retrovirus, we found that expression of murine NRSF from this
vector persisted longer than was observed using a nonintegrating
expression vector (Fig. 1 A, C, E, and G, and data not shown).
This apparent difference may reflect the integration of proviral
DNA into the host chromosome.
After unilateral electroporation of the RCAS-NRSF construct
into stage 12–13 chicken embryos and further incubation for 3
days, widespread expression of murine NRSF, detected with a
mouse-specific monoclonal antibody (12C11), was observed on
the electroporated but not the contralateral side of the spinal
cord within both the ventricular (Fig. 1 A, arrowhead) and
marginal (Fig. 1A, arrow) zones. The presence of NRSF-
expressing cells in the marginal zone suggested that sustained
expression of NRSF does not prevent the emigration of newly
generated neurons from the ventricular zone to their normal site
of differentiation. However, we cannot exclude that those cells
expressing murine NRSF in the marginal zone migrated from the
ventricular zone before elevated levels of exogenous NRSF
expression were achieved.
Immunostaining of adjacent sections with antibodies to either
N-tubulin or Ng-CAM revealed a down-regulation of these
markers caused by misregulation of NRSF. Overexpression of
NRSF within the ventricular zone resulted in repression of the
low level of N-tubulin expression normally seen in these neural
progenitors (Fig. 1 B and F, arrows) when compared with the
control contralateral side. No obvious decrease in N-tubulin
expression was observed in the marginal zone, however (Fig. 1F,
open arrowhead). In contrast, decreased expression of Ng-CAM
(which is normally not expressed in the ventricular zone) was
detected in the marginal zone in the axons of ventrally projecting
commissural neurons (Fig. 1 D and H, arrowheads). Electropo-
ration of a negative control construct expressing nuclear-
localized b-galactosidase revealed no difference between control
and electroporated sides in the expression of either N-tubulin or
Ng-CAM (data not shown).
No differences in the expression of other neuronal genes were
detected at this time point (data not shown). For example,
apparently equal numbers of cells expressing the pan-neuronal
cytoplasmic antigen cyn-1 (32) were detected on the NRSF-
overexpressing and control sides of the neural tube. In addition,
two other putative direct targets of NRSF, the growth-associated
protein, SCG10 (23), and middle molecular weight neurofila-
ment (9), did not exhibit obviously decreased levels of expression
in NRSF-electroporated embryos.
Alterations in Axon Pathfinding in NRSF-Overexpressing Neurons. The
sustained expression of NRSF could have affected the levels of
many other neuronal target genes for which appropriate anti-
bodies are not available. We therefore sought to assess more
generally the consequence of sustained NRSF expression for the
development of proper neuronal morphology and connectivity.
To this end, we adapted a system (34) for tracing the cellular
morphology and axonal projections of the cells that constitu-
tively expressed NRSF. An expression cassette (‘‘NTG’’) was
constructed in which the murine NRSF coding sequence was
followed by an internal ribosome entry site (IRES), followed by
a sequence encoding a fusion of the microtubule-associated
protein tau with the green fluorescent protein (tauGFP). This
design permitted visualization of the cell body morphology and
processes of cells expressing exogenous NRSF, using an antibody
to GFP. As a control, tauGFP was expressed alone (TG). To
evaluate axonal trajectories at early stages of development we
examined embryos at two rather than 3 days after electropora-
tion. This allowed use of a nonintegrating plasmid, pCS21 (28),
which is expressed more rapidly (35, 36) and at higher levels than
the retroviral vector. Repression of N-tubulin and Ng-CAM
expression by murine NRSF was seen with this plasmid expres-
sion system at the earlier time point as well (Fig. 2 A and B, arrow
and data not shown).
The NTG plasmid was electroporated into stage 13–14 chicken
embryos, and incubation of the eggs continued for 2 more days.
Immunostaining for NRSF revealed abundant expression of the
transgene in the ventricular and marginal zones on the electro-
porated side of the spinal cord (Fig. 2 A, arrowhead), as well as
in sensory neurons of the DRG (Fig. 2A, arrow). Double staining
with antibodies to NRSF and GFP indicated that the vast
majority of cells expressing one protein also expressed the other
(Fig. 2C). Some cells expressing NRSF at high levels showed
low-level GFP expression, but GFP-expressing cells that had
very low levels of NRSF were rare.
Visualization of the tauGFP fusion revealed that NRSF
overexpression did not prevent cells from attaining a neuronal
morphology. Sensory neurons expressing exogenous NRSF sent
axons into the spinal cord from the DRG (Figs. 2C and 3E,
arrows), and motor axons appeared to project normally out of
the spinal cord through the ventral root (Fig. 2C, open arrow-
head). The axons of NRSF-overexpressing commissural neurons,
however (whose cell bodies are located in the dorsolateral spinal
cord; Fig. 3C, open arrowhead), showed abnormalities in an
important aspect of their trajectory. These axons grew normally
toward the floor plate and were comparably fasciculated as those
in control embryos expressing tauGFP alone (TG; Fig. 3 C and
D, arrows). Many of the NTG-expressing commissural axons also
Fig. 2. Morphology of NRSF-misexpressing neurons identified by coexpres-
sion of tauGFP. Embryos were electroporated with the NTG expression con-
struct that encodes an NRSF-IRES-tauGFP cassette. A and C show a single
section double-stained with antibodies to NRSF (A) and GFP (C) visualized to
display either NRSF expression alone (A) or both NRSF and tauGFP expression
(C). B and D show an adjacent section double-stained with antibodies to
Ng-CAM (B) and GFP (D), visualized in a similar manner. Many cells expressing
exogenous NRSF show GFP staining (C); cells expressing GFP but not NRSF are
rare. NRSF-overexpressing sensory neurons in the DRG (A, arrow) send pro-
cesses into the dorsal spinal cord (C, arrow; see also Fig. 3E, arrow), whereas
motor neurons extend processes out of the ventral root (C, open arrowhead).
Expression of NRSF from this nonintegrating expression plasmid also represses
Ng-CAM expression in commissural (B, arrow) and sensory (B, arrowhead)
axons, as observed using the retroviral vector (cf. Fig. 1). Inappropriate pro-
jection of the axons of NRSF-overexpressing commissural neurons is found
within the contralateral commissural axon tract (C and D, arrowhead, green
process), in close association with Ng-CAM positive commissural axons that
have not yet crossed the midline (D, open arrowhead).
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crossed the ventral commissure beneath the floor plate (Fig. 3A,
open arrowhead). A number of these axons, however, failed to
immediately turn anteriorly into the ventral or lateral funiculi as
expected (37–39). Instead, they remained at the same rostro-
caudal level and projected dorsally, either within the neural tube
(Fig. 2 C and D, arrowheads and Fig. 3 A, C, and E, arrowheads)
or along the outer margin of the spinal cord (data not shown).
In some cases, decussated NTG-expressing axons appeared to
take a trajectory parallel to that taken by contralateral Ng-
CAM1 commissural axons (Fig. 2D, arrowheads).
Such pathfinding errors by decussated commissural axons
were significantly less frequent in embryos electroporated with
the control TG construct (Fig. 3 B, arrowhead, and D and F).
Quantification (see Materials and Methods) of the number of
stray axons on the contralateral side in an average of three
sections per embryo from each of 11 NTG-transfected and 7
TG-transfected embryos (from two independent experiments)
indicated that the mean frequency of stray axons per section was
4- to 5-fold higher in NTG-expressing (1.95 6 .29 errorsysection;
mean 6 SEM) than in TG-expressing (0.38 6 0.12 errors per
section) embryos (Fig. 4A, P , 0.001). A histogram of these data
also showed that the percentage of sections containing two or
more stray axons was significantly higher for NTG- than for
TG-expressing embryos (Fig. 4B). Thus, constitutive expression
of NRSF caused an increased frequency of axon guidance errors
by developing commissural axons.
Discussion
In this report we describe the effects of misregulating NRSF
expression in vivo in the developing nervous system of chicken
embryos. Exogenous NRSF was constitutively expressed in the
ventricular zone of the neural tube, resulting in higher-than-
normal levels of expression in neural progenitors and in sus-
tained expression in their progeny, where the endogenous gene
is normally down-regulated. The pattern of defects observed
suggests that down-regulation of endogenous NRSF in differ-
entiating neuronal precursors is necessary for both proper
induction of neuronal gene expression and for correct axon
pathfinding.
NRSF Overexpression Represses Endogenous Neuronal Target Genes.
Two neuronal genes that are direct targets of NRSF (9, 21) were
down-regulated by constitutive expression of NRSF in the
developing spinal cord. N-tubulin, which is normally expressed
at low levels in neural progenitors and is highly up-regulated in
differentiating neurons, was found to be repressed to almost
undetectable levels in those regions of the ventricular zone
Fig. 3. Constitutive expression of NRSF in commissural neurons causes axon
guidance errors. Sections stained with antibody to GFP are illustrated from
embryos electroporated with the NTG construct encoding NRSF (A, C, and E)
or the control TG construct encoding tauGFP alone (tauGFP; B, D, and F). In A
both bright field and epifluorescence images are superimposed. The floor-
plate (FP) is outlined by the dashed line and the midline decussation of
GFP-expressing axons is indicated by the open arrowhead. Solid arrowheads
indicate stray axons in the contralateral quadrant in this as well as the other
panels. Arrow indicates sensory neurons in the DRG. (C and D) Commissural
axons (open arrowhead) exhibit a similar extent of fasciculation on the
ipsilateral side of NRSF-expressing (C) and control (D) embryos (arrows), but
stray axons are visible in the NRSF-expressing embryo (C, arrowheads). Such
stray axons are occasionally seen in control embryos as well (B, arrowhead); see
Fig. 4 for quantification. Arrow in E indicates sensory axons growing toward
the dorsal spinal cord.
Fig. 4. Misexpression of NRSF causes a statistically significant increase in
axon guidance errors by commissural axons. (A) The average number of stray
axons per section is over 5-fold higher in NRSF-expressing (NTG) than in control
(TG) embryos (P , 0.001; see Materials and Methods for details). (B) Alternate
representation of the data illustrating a histogram of the percentage of
sections analyzed that contain stray commissural axons on the contralateral
side. The data are derived from analysis of approximately 40 sections from
11 NTG- and 7 TG-expressing embryos obtained in two independent
experiments.
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containing the highest levels of exogenous NRSF. Ng-CAM,
which is normally only detectable in differentiated neurons, was
repressed by NRSF in the marginal zone of the spinal cord.
Interestingly, Ng-CAM and N-tubulin were both de-repressed by
expression of a dominant-negative form of NRSF in chick
embryos (24). The symmetry of these loss- and gain-of-function
molecular phenotypes provides strong evidence that NRSF is
important in the negative regulation of these target genes in vivo.
The failure to detect repression of N-tubulin in the marginal zone
may reflect its expression in neurons that had differentiated
before high levels of exogenous NRSF expression were achieved.
Alternatively, the high baseline level of N-tubulin expression in
this region may obscure down-regulation of the marker in the
subset of neurons that overexpress NRSF.
Overexpression of NRSF caused repression of some but not all
of the target genes that we examined. The varying responsiveness
of NRSF target genes to perturbation of NRSF expression levels
by both loss- (24) and gain-of-function manipulations (this study)
in vivo is consistent with other studies. These studies have
indicated that the relative contribution of NRSF to the tran-
scriptional regulation of a given reporter gene depends on what
other regulatory elements are present in the promoter (12, 17),
as well as on the cellular context (18, 21, 22, 24, 40, 41). Thus,
both inhibition and increase of NRSF function leads to the
conclusion that the relative importance of NRSF for maintaining
repression is gene- as well as cell-type-dependent (see ref. 24 for
detailed discussion).
Relationship of NRSF to Transcriptional Inhibitors of Neurogenesis.
Although constitutive expression of NRSF down-regulated a
subset of neuronal genes, it did not appear to prevent overt
neurogenesis: many NRSF-expressing cells could be observed in
the mantle layer, and they coexpressed neuronal markers such as
SCG10, neurofilament, and cyn-1. In contrast, overexpression of
another negative regulator, Hes1 (4), in neural progenitors of the
forebrain prevented cells from migrating out of the ventricular
zone (5), and in both forebrain and retina prevented overt
neuronal differentiation (5, 6).
The apparently different biological activities of NRSFyRest
and Hes genes in gain-of-function experiments may reflect
differences between the levels of the neurogenic regulatory
hierarchy at which these genes act. The only known direct targets
of Hes1 are two transcription factors: Hes1 itself (42) and the
neuronal differentiation gene, hASH1 (43). Furthermore, Hes1
is not only able to repress the transcription of positive regulators
of neurogenesis such as ASH genes, but because of its helix–
loop–helix structure, it is also able to directly inhibit their
function by heterodimerization. Therefore, Hes1 acts by several
mechanisms to inhibit regulatory factors that function at early
steps in the genetic hierarchy controlling neurogenesis. The
known targets of NRSF, by contrast, appear primarily to be
structural rather than regulatory genes (9). The inability of
NRSF to inhibit neurogenesis may thus be explained by the fact
that it does not repress early-acting positive regulators of the
neurogenic differentiation program. Consistent with this, misex-
pression of NRSF did not prevent expression of the basic
helix–loop–helix neuronal determination gene neurogenin2 (44)
in the spinal cord (data not shown).
Overexpression of NRSF in Neurons Perturbs Axon Pathfinding. Over-
expression of NRSF in spinal cord commissural neurons caused
axon pathfinding defects. The axons of some of these neurons did
not turn anteriorly into the longitudinal axis after crossing the
floor plate, as they normally do (37–39). Rather, they continued
in the same rostrocaudal segment of the spinal cord and pro-
jected dorsally. Such aberrant projections were also detected in
control embryos expressing the TG construct, but at a signifi-
cantly lower frequency. Interestingly, loss-of-function genetic
perturbations of axon guidance molecules often appear to sta-
bilize aberrant projections, which occur transiently during nor-
mal development but are subsequently corrected (45). The effect
of NRSF misexpression on axon guidance is therefore similar to
the kind of phenotype that would be expected from down-
regulating multiple axon guidance components. The fact that
guidance errors are detected only after commissural axons have
crossed the midline may reflect the fact that proper guidance of
such decussated axons requires changes in the expression levels
of several cell surface proteins (ref. 46; reviewed in refs. 47 and
48). Perhaps forced expression of NRSF inhibits the postde-
cussational induction of some of these guidance factors.
Constitutive expression of NRSF caused a down-regulation of
Ng-CAM expression in commissural axons. In earlier experi-
ments, injection of function-blocking antibodies against Ng-
CAM into the neural tube of chick embryos was shown to cause
defasciculation of commissural axons before decussation (49). In
contrast, there was no apparent defasciculation of commissural
axons on the ipsilateral side of NRSF-misexpressing embryos,
relative to controls. There is not necessarily any inconsistency
between these observations. It is not uncommon for axon
guidance phenotypes to be more severe when guidance mole-
cules are perturbed immunologically rather than genetically
(e.g., see refs. 45 and 49–51). This may reflect a lesser degree of
specificity of the immune reagents, either because of antibody
cross-reactivity or secondary effects on other guidance mole-
cules associated with the primary antigenic target. Alternatively,
the antibodies may have achieved a more complete inhibition of
Ng-CAM function than was caused by transcriptional down-
regulation of Ng-CAM expression.
A more likely explanation, however, is that inhibition of
Ng-CAM function yields a different phenotype than does NRSF
misexpression, because there are potentially dozens of other
target genes in addition to Ng-CAM that may be down-regulated
by forced expression of NRSF (52). If these target genes include
those encoding other guidance molecules that normally function
in opposition to (or whose function is negatively regulated by)
Ng-CAM itself (e.g., see ref. 53), then the down-regulation of
these other molecules by NRSF could counteract or modify its
effect to down-regulate Ng-CAM.
The potential multiplicity of NRSF targets may also explain
why NRSF caused guidance errors by decussated commissural
axons on the contralateral side, whereas injection of Ng-CAM
antibodies did not (49). However, it is important to note that the
antibody injection was a bilateral manipulation, whereas NRSF
was misexpressed only on one side of the spinal cord. Therefore,
in the present experiments decussated commissural axons misex-
pressing NRSF should encounter normal levels of Ng-CAM
expression on the contralateral side, whereas in the antibody
injection experiments Ng-CAM function would be neutralized
on both sides of the spinal cord. It would be interesting to test
the effects of unilateral neutralization of Ng-CAM function on
commissural axon guidance. However, we wish to emphasize that
we feel it is unlikely that the axon guidance defects caused by
NRSF misexpression can be explained solely by its effect on
Ng-CAM expression. An understanding of the molecular mech-
anism whereby NRSF misexpression affects axon guidance will
require a more systematic analysis of the target genes that are
negatively regulated by NRSF in commissural neurons.
The present results provide the first in vivo gain-of-function
data for NRSF. They indicate that the down-regulation of
endogenous NRSF expression that normally occurs during neu-
rogenesis may be important for those aspects of neural devel-
opment that require a fine-tuning of gene expression, such as
axon guidance. By extension, the persistent expression of NRSF
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mRNA observed in adult neurons (25) could reflect a role to
quantitatively modulate the expression of genes underlying
neuronal plasticity (54). Consistent with this idea, the NRSE has
been found to be important in preventing overactivation of the
BDNF promoter in response to kainic acid-induced seizures in
adult mice (18). The fact that only a subset of its potential target
genes are down-regulated by NRSF misexpression in neurons
may, therefore, reflect mechanisms that normally allow endog-
enous NRSF to be used to selectively regulate certain phenotypic
properties in differentiated neurons while preventing deleterious
repression of its many other targets.
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